Recombinant insig1 is synthesized using heterologous expression systems:
Insig1 regulates cholesterol biosynthesis via two mechanisms:
SCAP-SREBP Retention: Binds SCAP-SREBP complexes in the ER, blocking proteolytic activation of SREBP transcription factors .
HMGCR Degradation: Recruits E3 ubiquitin ligases (e.g., TRC8) to degrade HMG-CoA reductase, a rate-limiting enzyme in cholesterol synthesis .
Zebrafish insig1 shares 85% membrane domain homology with human INSIG1/2, enabling cross-species functional studies .
Asp-205 (zebrafish numbering) is critical for SCAP/HMGCR binding .
Insig1 inhibits HIV-1 replication by degrading the viral Gag protein via lysosomal pathways :
Mechanism: Partners with E3 ligase TRC8 to ubiquitinate Gag, targeting it for lysosomal degradation .
Experimental Evidence:
Antibodies: Rabbit polyclonal antibodies against zebrafish insig1 are available for ELISA and Western blot .
Mutant Variants: Truncations of the KH motif or sterol-sensing domain are used to study functional domains .
Stability: Requires storage at -80°C for long-term preservation .
Species-Specificity: While structurally similar to mammalian INSIG1, zebrafish insig1 may exhibit functional divergences in lipid regulation .
Insulin-induced gene 1 protein (insig1) in zebrafish (Danio rerio) serves as an endoplasmic reticulum membrane protein that regulates cholesterol metabolism, lipogenesis, and glucose homeostasis. Similar to its mammalian counterpart, zebrafish insig1 contains transmembrane helices with effector protein binding sites that enable interaction with sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase). These interactions are essential for sterol-mediated trafficking of these proteins, which ultimately control cholesterol synthesis and metabolism .
While the search results don't provide specific structural comparisons between zebrafish and human insig1, we can infer similarities based on data about the related insig2 protein. Insig-2 is 80% identical between zebrafish and humans, with most variations occurring in the hydrophilic NH2- and COOH-terminal sequences . This high conservation suggests that insig1 likely maintains significant structural homology between species as well, though possibly with less conservation than insig2, as insig2 is noted to be more highly conserved among vertebrate species than insig1 .
The critical functional domains of zebrafish insig1 include its transmembrane helices that contain binding sites for SCAP and HMG-CoA reductase. These domains enable insig1 to mediate feedback control of cholesterol synthesis by controlling endoplasmic reticulum to Golgi transport of SCAP and degradation of HMG-CoA reductase . The protein's ability to bind oxysterols, including 25-hydroxycholesterol, is also crucial for regulating its interaction with SCAP and the retention of the SCAP-SREBP complex in the endoplasmic reticulum .
While the search results don't directly address expression systems for recombinant zebrafish insig1, researchers typically use bacterial systems (E. coli), yeast (Saccharomyces cerevisiae), insect cells (Sf9, Sf21), or mammalian cell lines (HEK293, CHO) for expressing recombinant proteins. For membrane proteins like insig1 that contain multiple transmembrane domains, eukaryotic expression systems such as insect cells or mammalian cells may provide better folding and post-translational modifications. When designing expression constructs, researchers should consider codon optimization for the expression host and include appropriate purification tags (His, FLAG, GST) that don't interfere with protein function .
Functional validation of recombinant zebrafish insig1 can be accomplished through several complementary approaches:
Binding assays: Test the recombinant protein's ability to bind known partners like SCAP and HMG-CoA reductase using co-immunoprecipitation or pull-down assays.
Cholesterol regulation assays: Measure the protein's ability to regulate cholesterol synthesis in cellular systems, such as CHO cell lines (e.g., SRD-13A cells) .
Sterol-dependent retention assays: Assess whether the recombinant protein can mediate sterol-dependent retention of the SCAP/SREBP complex in the endoplasmic reticulum.
Rescue experiments: Test if the recombinant protein can restore normal function in insig1-deficient zebrafish or cell lines.
Oxysterol binding assays: Verify the protein's ability to bind oxysterols like 25-hydroxycholesterol .
While the search results don't specifically address optimal developmental stages for studying insig1 in zebrafish, researchers typically work with embryos, larvae, and adult zebrafish depending on the research question. For developmental studies, researchers often observe zebrafish at specific hours post-fertilization (hpf): 24 hpf, 48 hpf, 72 hpf, and 96 hpf, as detailed in the zebrafish embryo development protocols . When studying the metabolism-related functions of insig1, larval stages may be particularly useful as demonstrated in insulin administration studies where human recombinant insulin was injected into the caudal aorta of zebrafish larvae .
While the search results don't directly link insig1 to zebrafish diabetes models, they provide context for how such relationships might be studied. Zebrafish diabetes models, created through insulin administration or dietary manipulation, can be used to study how insig1 responds to altered metabolic states . In these models, researchers could examine changes in insig1 expression or function following hyperinsulinemia induction. The relationship between insulin signaling and insig1 could be studied by examining how hyperinsulinemic conditions (created by incubating larvae in high-insulin solutions) affect insig1-mediated regulation of lipid metabolism genes .
Recombinant insig1 protein can serve as a powerful tool for investigating zebrafish lipid metabolism through several experimental approaches:
In vitro binding studies to identify zebrafish-specific interacting partners in lipid metabolism pathways.
Structure-function analyses to determine how the protein regulates enzymes involved in lipid synthesis.
Reconstitution experiments in insig1-deficient systems to confirm direct effects on lipid metabolism.
Comparative studies between zebrafish and mammalian systems to identify conserved and divergent mechanisms of lipid regulation.
These approaches can help elucidate insig1's role in mediating feedback control of cholesterol synthesis by regulating SCAP transport and HMG-CoA reductase degradation in zebrafish .
While specific data on this relationship is not provided in the search results, we can infer from studies on insulin administration in zebrafish that potential connections exist. When human recombinant insulin was injected into zebrafish larvae, researchers observed downregulation of genes involved in insulin metabolism (insr, irs1, irs2, pik3cb) . By extension, investigating how insig1 manipulation affects these same genes could reveal important connections between insig1 function and insulin responsiveness. Researchers could use techniques like qPCR or RNA-seq to measure changes in insulin-responsive gene expression following insig1 overexpression or knockdown in zebrafish models .
Creating effective zebrafish insig1 knockout models may present several challenges:
Potential functional redundancy between insig1 and the highly conserved insig2, which could mask phenotypes in single insig1 knockout models .
Possible developmental defects that might arise from early knockout if insig1 has essential roles in embryonic development.
The need to verify knockout efficiency at both the genomic DNA level (e.g., sequencing) and protein level (e.g., Western blot).
Addressing potential off-target effects when using CRISPR-Cas9 or other genome editing approaches.
Designing appropriate assays to detect subtle metabolic phenotypes that might result from insig1 knockout, especially in relation to cholesterol metabolism and insulin responsiveness.
Researchers should consider these challenges when designing knockout strategies and interpreting resulting phenotypes.
To study interactions between zebrafish insig1 and SREBP pathway components, consider the following experimental design approaches:
Co-immunoprecipitation assays using tagged recombinant proteins to identify direct binding partners.
FRET or BiFC assays to visualize protein-protein interactions in living cells.
Sterol depletion/loading experiments to determine how sterols affect the interaction between insig1 and SCAP in zebrafish cells.
Mutational analysis of the sterol-sensing domain of SCAP to identify residues critical for interaction with zebrafish insig1.
Subcellular localization studies using fluorescently tagged proteins to track SCAP/SREBP complex movement in the presence or absence of insig1 and sterols.
These approaches can help elucidate how zebrafish insig1 functions in the sterol-mediated retention of the SCAP/SREBP complex in the endoplasmic reticulum .
When studying recombinant insig1 in zebrafish diabetes models, researchers should control for several potential confounding factors:
Dietary composition differences: Standard zebrafish feed contains higher protein and lower carbohydrate levels compared to human diets, which affects insulin's role in glucose regulation and may influence insig1 function .
Developmental stage variations: The response to metabolic perturbations can vary significantly depending on the developmental stage of the zebrafish.
Method of diabetes induction: Different methods (genetic, chemical, dietary, or insulin injection) may affect insig1 function differently .
Expression level artifacts: Overexpression of recombinant insig1 may lead to non-physiological interactions or saturation of binding partners .
Endogenous insig1 and insig2 contributions: The presence of endogenous proteins may complicate interpretation of recombinant protein effects .
Controlling for these factors through appropriate experimental design and controls is essential for obtaining reliable and physiologically relevant results.
Based on the search results, we can identify several key differences between insig1 and insig2 proteins, though not all are specifically described for zebrafish:
Conservation level: Insig2 is more highly conserved among vertebrate species than insig1. Zebrafish and human insig2 share 80% sequence identity, while the conservation level for insig1 appears to be lower .
Structural differences: Most variations between these proteins occur in the hydrophilic NH2- and COOH-terminal sequences rather than in the transmembrane domains .
Regulatory mechanisms: Though not explicitly stated for zebrafish, in other systems insig1 and insig2 may have different expression patterns or responsiveness to metabolic stimuli.
These differences suggest that while both proteins may serve similar fundamental functions in cholesterol metabolism regulation, they likely have distinct roles or regulatory mechanisms that complement each other in maintaining metabolic homeostasis.
| Concentration | # of starting fish | # alive 24 hpf | # alive 48 hpf | # alive 72 hpf | # alive 96 hpf |
|---|---|---|---|---|---|
| Control | 40 | 34 | 28 | 26 | 25 |
| 0.05 mg/mL | 40 | 33 | 30 | 26 | 22 |
| 0.25 mg/mL | 40 | 36 | 35 | 35 | 32 |
| 1 mg/mL | 40 | 39 | 39 | 15 | 0 |
Note: While this survival rate data is from a caffeine exposure study , similar experimental design could be applied to studies investigating the effects of recombinant insig1 protein on zebrafish development and metabolism.
While the search results don't provide zebrafish-specific methods for studying insig1-mediated regulation, several approaches used in related research could be adapted:
Gene expression analysis: Monitoring the expression of phosphoenolpyruvate carboxykinase 1 (pck1) and other metabolism-related genes following manipulation of insig1 levels, similar to the approach used in insulin administration studies .
Protein-protein interaction assays: Studying the binding between insig1 and SCAP or HMG-CoA reductase using techniques like those applied to investigate insig2 function .
Subcellular localization studies: Tracking the movement of SCAP/SREBP complexes between the endoplasmic reticulum and Golgi in response to sterol levels and insig1 expression .
Metabolic assays: Measuring cholesterol synthesis, lipogenesis, and glucose metabolism in zebrafish with altered insig1 expression or activity.
Hyperinsulinemic zebrafish models: Using established methods for creating insulin resistance in zebrafish to study insig1's role in metabolic dysregulation .
Researchers would need to determine appropriate delivery methods (e.g., microinjection into embryos or addition to embryo media), concentrations, and timing of administration. Additionally, molecular markers of cholesterol metabolism, lipogenesis, and related developmental pathways should be monitored to understand the mechanistic basis of any observed developmental effects.